Helen Parker

Helen Parker is a seasoned professional in the medical science liaison field, currently serving as a Senior Medical Science Liaison at NewAmsterdam Pharma since April 2024. Previous roles include Associate Director at Milestone Pharmaceuticals, Senior Medical Science Liaison at Relmada Therapeutics and BioXcel Therapeutics, and Director at Titan Pharmaceuticals. Helen's experience encompasses acting as a Medical Science Liaison at Aptevo Therapeutics and Braeburn, where responsibilities included engaging with key opinion leaders and healthcare professionals, presenting scientific data, and participating in training programs. Helen also served as a Cardiovascular Clinical Nurse Educator during a pivotal time for PCSK9 inhibitors and has a robust nursing background, holding positions in emergency care and clinical education. Educational qualifications include a Master's Degree as a Family Nurse Practitioner and a Bachelor's Degree in Nursing from Florida International University.